Potential of IL-1, IL-18 and Inflammasome Inhibition for the Treatment of Inflammatory Skin Diseases
出版年份 2017 全文链接
标题
Potential of IL-1, IL-18 and Inflammasome Inhibition for the Treatment of Inflammatory Skin Diseases
作者
关键词
-
出版物
Frontiers in Pharmacology
Volume 8, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2017-05-22
DOI
10.3389/fphar.2017.00278
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Efficacy and safety of canakinumab in Schnitzler syndrome: A multicenter randomized placebo-controlled study
- (2017) Karoline Krause et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- MABp1 as a novel antibody treatment for advanced colorectal cancer: a randomised, double-blind, placebo-controlled, phase 3 study
- (2017) Tamas Hickish et al. LANCET ONCOLOGY
- Anakinra for Colchicine-Resistant Familial Mediterranean Fever: A Randomized, Double-Blind, Placebo-Controlled Trial
- (2017) Ilan Ben-Zvi et al. Arthritis & Rheumatology
- IL-1 Vaccination Is Suitable for Treating Inflammatory Diseases
- (2017) Eric Assier et al. Frontiers in Pharmacology
- Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): an open-label, phase II study
- (2016) Marco Gattorno et al. ANNALS OF THE RHEUMATIC DISEASES
- Systemic-onset juvenile idiopathic arthritis
- (2016) Rolando Cimaz AUTOIMMUNITY REVIEWS
- Adult-onset Still's disease: Advances in the treatment
- (2016) Santos Castañeda et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- PSTPIP1gene mutation in a pyoderma gangrenosum, acne and suppurative hidradenitis (PASH) syndrome
- (2016) X. Calderón-Castrat et al. BRITISH JOURNAL OF DERMATOLOGY
- Germline NLRP1 Mutations Cause Skin Inflammatory and Cancer Susceptibility Syndromes via Inflammasome Activation
- (2016) Franklin L. Zhong et al. CELL
- Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet’s disease-related uveitis: a multicenter retrospective observational study
- (2016) Claudia Fabiani et al. CLINICAL RHEUMATOLOGY
- PASS Syndrome: An IL-1-Driven Autoinflammatory Disease
- (2016) Mathieu Leuenberger et al. DERMATOLOGY
- K + Efflux-Independent NLRP3 Inflammasome Activation by Small Molecules Targeting Mitochondria
- (2016) Christina J. Groß et al. IMMUNITY
- Interleukin-1 receptor antagonist (anakinra) for Schnitzler syndrome
- (2016) Astrid Sönnichsen et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Behçet's disease: A comprehensive review with a focus on epidemiology, etiology and clinical features, and management of mucocutaneous lesions
- (2016) Erkan Alpsoy JOURNAL OF DERMATOLOGY
- NLRP3 recruitment by NLRC4 duringSalmonellainfection
- (2016) Yan Qu et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Efficacy and Pharmacology of the NLRP3 Inflammasome Inhibitor CP-456,773 (CRID3) in Murine Models of Dermal and Pulmonary Inflammation
- (2016) Michael J. Primiano et al. JOURNAL OF IMMUNOLOGY
- Molecular mechanisms of regulation of Toll-like receptor signaling
- (2016) Cynthia A. Leifer et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Longterm Beneficial Effect of Canakinumab in Colchicine-resistant Familial Mediterranean Fever
- (2016) Katerina Laskari et al. JOURNAL OF RHEUMATOLOGY
- High level of serum human interleukin-18 in a patient with pyogenic arthritis, pyoderma gangrenosum and acne syndrome
- (2016) S. Kanameishi et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Development of an Interleukin-1β Vaccine in Patients with Type 2 Diabetes
- (2016) Claudia Cavelti-Weder et al. MOLECULAR THERAPY
- NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux
- (2016) Yuan He et al. NATURE
- Interleukin 1α and the inflammatory process
- (2016) Nelson C Di Paolo et al. NATURE IMMUNOLOGY
- Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS
- (2016) Yong Hwan Park et al. NATURE IMMUNOLOGY
- A Study to Investigate the Efficacy and Safety of an Anti-Interleukin-18 Monoclonal Antibody in the Treatment of Type 2 Diabetes Mellitus
- (2016) Elizabeth A. McKie et al. PLoS One
- Familial autoinflammation with neutrophilic dermatosis reveals a regulatory mechanism of pyrin activation
- (2016) Seth L. Masters et al. Science Translational Medicine
- Crystal structure of NOD2 and its implications in human disease
- (2016) Sakiko Maekawa et al. Nature Communications
- Functional and Evolutionary Analyses Identify Proteolysis as a General Mechanism for NLRP1 Inflammasome Activation
- (2016) Joseph Chavarría-Smith et al. PLoS Pathogens
- SAPHO Syndrome: Current Developments and Approaches to Clinical Treatment
- (2016) Davide Firinu et al. Current Rheumatology Reports
- Safety and Efficacy of Anakinra in Severe Hidradenitis Suppurativa
- (2016) Vassiliki Tzanetakou et al. JAMA Dermatology
- The Phenotype and Genotype of Mevalonate Kinase Deficiency: A Series of 114 Cases From the Eurofever Registry
- (2016) Nienke M. ter Haar et al. Arthritis & Rheumatology
- IL-1 Inhibition in Systemic Juvenile Idiopathic Arthritis
- (2016) Gabriella Giancane et al. Frontiers in Pharmacology
- Curcumin Represses NLRP3 Inflammasome Activation via TLR4/MyD88/NF-κB and P2X7R Signaling in PMA-Induced Macrophages
- (2016) Fanqi Kong et al. Frontiers in Pharmacology
- Commensal Bacteria-Induced Inflammasome Activation in Mouse and Human Macrophages Is Dependent on Potassium Efflux but Does Not Require Phagocytosis or Bacterial Viability
- (2016) Kejie Chen et al. PLoS One
- Two cases of severe hidradenitis suppurativa with failure of anakinra therapy
- (2015) D. Menis et al. BRITISH JOURNAL OF DERMATOLOGY
- First nicastrin mutation in PASH (pyoderma gangrenosum, acne and suppurative hidradenitis) syndrome
- (2015) S. Duchatelet et al. BRITISH JOURNAL OF DERMATOLOGY
- Keratinocytes and neutrophils are important sources of proinflammatory molecules in hidradenitis suppurativa
- (2015) A.L. Lima et al. BRITISH JOURNAL OF DERMATOLOGY
- Canakinumab in adults with steroid-refractory pyoderma gangrenosum
- (2015) A.G.A. Kolios et al. BRITISH JOURNAL OF DERMATOLOGY
- Treatment of two patients with generalized pustular psoriasis with the interleukin-1β inhibitor gevokizumab
- (2015) B. Mansouri et al. BRITISH JOURNAL OF DERMATOLOGY
- Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion
- (2015) Wan-ting He et al. CELL RESEARCH
- Efficacy and safety profile of anti-interleukin-1 treatment in Behçet’s disease: a multicenter retrospective study
- (2015) Giacomo Emmi et al. CLINICAL RHEUMATOLOGY
- Severe Sweet's Syndrome with Elevated Cutaneous Interleukin-1β after Azathioprine Exposure: Case Report and Review of the Literature
- (2015) Laurence Imhof et al. DERMATOLOGY
- Proteolytic Processing of Interleukin-1 Family Cytokines: Variations on a Common Theme
- (2015) Inna S. Afonina et al. IMMUNITY
- Resveratrol inhibits NLRP3 inflammasome activation by preserving mitochondrial integrity and augmenting autophagy
- (2015) Ya-Ping Chang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Safety, pharmacokinetics, and preliminary efficacy of a specific anti-IL-1alpha therapeutic antibody (MABp1) in patients with type 2 diabetes mellitus
- (2015) Katharina Timper et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- PsAPASH: A new syndrome associated with hidradenitis suppurativa with response to tumor necrosis factor inhibition
- (2015) Rosita Saraceno et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling
- (2015) Nobuhiko Kayagaki et al. NATURE
- Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death
- (2015) Jianjin Shi et al. NATURE
- NLRP3 activation and mitosis are mutually exclusive events coordinated by NEK7, a new inflammasome component
- (2015) Hexin Shi et al. NATURE IMMUNOLOGY
- The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome–mediated inflammatory disease
- (2015) Yun-Hee Youm et al. NATURE MEDICINE
- A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
- (2015) Rebecca C Coll et al. NATURE MEDICINE
- Protective effect of neutralizing anti-IL-18α monoclonal antibody on a mouse model of acute graft-versus-host disease
- (2015) XIAOCUI LI et al. ONCOLOGY REPORTS
- Long-term efficacy and safety of Canakinumab in active Hyper-IgD syndrome (HIDS): results from an open-label study
- (2015) JI Aróstegui et al. Pediatric Rheumatology
- Neutrophilic dermatoses and autoinflammatory diseases with skin involvement—innate immune disorders
- (2015) Alexander A. Navarini et al. Seminars in Immunopathology
- The novel S59P mutation in the TNFRSF1A gene identified in an adult onset TNF receptor associated periodic syndrome (TRAPS) constitutively activates NF-κB pathway
- (2015) Eliana Greco et al. ARTHRITIS RESEARCH & THERAPY
- Efficacy and safety of canakinumab in adolescents and adults with colchicine-resistant familial Mediterranean fever
- (2015) Ahmet Gül et al. ARTHRITIS RESEARCH & THERAPY
- Bruton’s tyrosine kinase is essential for NLRP3 inflammasome activation and contributes to ischaemic brain injury
- (2015) Minako Ito et al. Nature Communications
- Reporting of MABp1 for the Treatment of Psoriasis
- (2015) Bobbak Mansouri et al. JAMA Dermatology
- Open-Label Trial of MABp1, a True Human Monoclonal Antibody Targeting Interleukin 1α, for the Treatment of Psoriasis
- (2015) Kyle M. Coleman et al. JAMA Dermatology
- Population Pharmacokinetic Modeling of LY2189102 after Multiple Intravenous and Subcutaneous Administrations
- (2014) Sébastien Bihorel et al. AAPS Journal
- A 24-month open-label study of canakinumab in neonatal-onset multisystem inflammatory disease
- (2014) Cailin H Sibley et al. ANNALS OF THE RHEUMATIC DISEASES
- IL-1 Blockade in Autoinflammatory Syndromes
- (2014) Adriana A. Jesus et al. Annual Review of Medicine
- Expression of cytokines, chemokines and other effector molecules in two prototypic autoinflammatory skin diseases, pyoderma gangrenosum and Sweet's syndrome
- (2014) A. V. Marzano et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Inhibition of Interleukin-1 by Canakinumab as a Successful Mono-Drug Strategy for the Treatment of Refractory Behçet's Disease: A Case Series
- (2014) Antonio Vitale et al. DERMATOLOGY
- Malasseziayeasts activate the NLRP3 inflammasome in antigen-presenting cells via Syk-kinase signalling
- (2014) Magdalena Kistowska et al. EXPERIMENTAL DERMATOLOGY
- Canakinumab in a case of Adult onset Still's disease: Efficacy only on systemic manifestations
- (2014) Alberto Lo Gullo et al. JOINT BONE SPINE
- The Lysosome Rupture-activated TAK1-JNK Pathway Regulates NLRP3 Inflammasome Activation
- (2014) Masahiro Okada et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cyclooxygenase-2 Regulates NLRP3 Inflammasome-Derived IL-1β Production
- (2014) Kuo-Feng Hua et al. JOURNAL OF CELLULAR PHYSIOLOGY
- An inherited mutation inNLRC4causes autoinflammation in human and mice
- (2014) Akiko Kitamura et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Propionibacterium acnes Activates the NLRP3 Inflammasome in Human Sebocytes
- (2014) Zheng Jun Li et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Tumor necrosis factor receptor-associated periodic syndrome as a model linking autophagy and inflammation in protein aggregation diseases
- (2014) Tiziana Bachetti et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Expression of interleukin-1 alpha in amicrobial pustulosis of the skin folds with complete response to anakinra
- (2014) Emmanuelle Amazan et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- MABp1, a first-in-class true human antibody targeting interleukin-1α in refractory cancers: an open-label, phase 1 dose-escalation and expansion study
- (2014) David S Hong et al. LANCET ONCOLOGY
- A novel human anti-interleukin-1β neutralizing monoclonal antibody showing in vivo efficacy
- (2014) Angeline XH Goh et al. mAbs
- Association of Pyoderma Gangrenosum, Acne, and Suppurative Hidradenitis (PASH) Shares Genetic and Cytokine Profiles With Other Autoinflammatory Diseases
- (2014) Angelo V. Marzano et al. MEDICINE
- Inflammatory caspases are innate immune receptors for intracellular LPS
- (2014) Jianjin Shi et al. NATURE
- Mutation of NLRC4 causes a syndrome of enterocolitis and autoinflammation
- (2014) Neil Romberg et al. NATURE GENETICS
- An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome
- (2014) Scott W Canna et al. NATURE GENETICS
- Bacterial RNA:DNA hybrids are activators of the NLRP3 inflammasome
- (2014) S. Kailasan Vanaja et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CARD8 is a negative regulator for NLRP3 inflammasome, but mutant NLRP3 in cryopyrin-associated periodic syndromes escapes the restriction
- (2014) Sayaka Ito et al. ARTHRITIS RESEARCH & THERAPY
- Brief Report: Involvement ofTNFRSF11AMolecular Defects in Autoinflammatory Disorders
- (2014) Isabelle Jéru et al. Arthritis & Rheumatology
- Canakinumab for the Treatment of Children With Colchicine-Resistant Familial Mediterranean Fever: A 6-Month Open-Label, Single-Arm Pilot Study
- (2014) Riva Brik et al. Arthritis & Rheumatology
- Pattern Recognition and Signaling Mechanisms of RIG-I and MDA5
- (2014) Stephanie Reikine et al. Frontiers in Immunology
- Successful Treatment of Generalized Pustular Psoriasis With the Interleukin-1-Receptor Antagonist Anakinra: Lack of Correlation With IL1RN Mutations
- (2013) Manuelle Viguier ANNALS OF INTERNAL MEDICINE
- Successful Treatment of Tumor Necrosis Factor Receptor–Associated Periodic Syndrome With Canakinumab
- (2013) Maria Giuseppina Brizi et al. ANNALS OF INTERNAL MEDICINE
- Rilonacept for Colchicine-Resistant or -Intolerant Familial Mediterranean Fever
- (2013) Philip J. Hashkes et al. ANNALS OF INTERNAL MEDICINE
- Long-Term Safety and Efficacy of Rilonacept in Patients With Systemic Juvenile Idiopathic Arthritis
- (2013) Daniel J. Lovell et al. ARTHRITIS AND RHEUMATISM
- Anakinra treatment in drug-resistant Behcet’s disease: a case series
- (2013) Luca Cantarini et al. CLINICAL RHEUMATOLOGY
- Failure of Anti-Interleukin-1 Therapy in Severe Hidradenitis Suppurativa: A Case Report
- (2013) H.H. van der Zee et al. DERMATOLOGY
- Double-Blind, Randomized Study Evaluating the Glycemic and Anti-inflammatory Effects of Subcutaneous LY2189102, a Neutralizing IL-1 Antibody, in Patients With Type 2 Diabetes
- (2013) J. Sloan-Lancaster et al. DIABETES CARE
- K+ Efflux Is the Common Trigger of NLRP3 Inflammasome Activation by Bacterial Toxins and Particulate Matter
- (2013) Raúl Muñoz-Planillo et al. IMMUNITY
- Divergence of IL-1, IL-18, and cell death in NLRP3 inflammasomopathies
- (2013) Susannah D. Brydges et al. JOURNAL OF CLINICAL INVESTIGATION
- The Nlrp3 inflammasome regulates acute graft-versus-host disease
- (2013) Dragana Jankovic et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IL-1β Drives Inflammatory Responses to Propionibacterium acnes In Vitro and In Vivo
- (2013) Magdalena Kistowska et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Propionibacterium acnes Induces IL-1β Secretion via the NLRP3 Inflammasome in Human Monocytes
- (2013) Min Qin et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- An open-label study of anakinra for the treatment of moderate to severe hidradenitis suppurativa
- (2013) Kieron S. Leslie et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Phosphorylation of the adaptor ASC acts as a molecular switch that controls the formation of speck-like aggregates and inflammasome activity
- (2013) Hideki Hara et al. NATURE IMMUNOLOGY
- The interleukin-1 receptor family
- (2013) Diana Boraschi et al. SEMINARS IN IMMUNOLOGY
- Successful Treatment of Severe Hidradenitis Suppurativa With Anakinra
- (2013) Kian Zarchi et al. JAMA Dermatology
- Pyogenic Arthritis, Pyoderma Gangrenosum, Acne, and Hidradenitis Suppurativa (PAPASH): A New Autoinflammatory Syndrome Associated With a Novel Mutation of the PSTPIP1 Gene
- (2013) Angelo V. Marzano et al. JAMA Dermatology
- Identification of a Homozygous PSTPIP1 Mutation in a Patient With a PAPA-Like Syndrome Responding to Canakinumab Treatment
- (2013) Alexandra Geusau et al. JAMA Dermatology
- Interleukin-18 and IL-18 Binding Protein
- (2013) Charles A. Dinarello et al. Frontiers in Immunology
- Unsolved Mysteries in NLR Biology
- (2013) Christopher Lupfer et al. Frontiers in Immunology
- The Interleukin-1α Precursor is Biologically Active and is Likely a Key Alarmin in the IL-1 Family of Cytokines
- (2013) Busun Kim et al. Frontiers in Immunology
- Efficacy and safety of the interleukin-1 antagonist rilonacept in Schnitzler syndrome: an open-label study
- (2012) K. Krause et al. ALLERGY
- IL-1 Trap rilonacept in refractory adult onset Still's disease
- (2012) Olga Petryna et al. ANNALS OF THE RHEUMATIC DISEASES
- Sustained efficacy of the monoclonal anti-interleukin-1 beta antibody canakinumab in a 9-month trial in Schnitzler's syndrome
- (2012) Heleen D de Koning et al. ANNALS OF THE RHEUMATIC DISEASES
- Anakinra treatment of SAPHO syndrome: short-term results of an open study
- (2012) Daniel Wendling et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical and transcriptional response to the long-acting interleukin-1 blocker canakinumab in Blau syndrome-related uveitis
- (2012) Gabriele Simonini et al. ARTHRITIS AND RHEUMATISM
- Diagnosis and management of acute graft-versus-host disease
- (2012) Fiona L. Dignan et al. BRITISH JOURNAL OF HAEMATOLOGY
- A novel mutation in the interleukin-1 receptor antagonist associated with intrauterine disease onset
- (2012) Ender Altiok et al. CLINICAL IMMUNOLOGY
- Specific inflammasomes in complex diseases
- (2012) Seth L. Masters CLINICAL IMMUNOLOGY
- Mevalonate kinase deficiency, a metabolic autoinflammatory disease
- (2012) Robert van der Burgh et al. CLINICAL IMMUNOLOGY
- The Malassezia Genus in Skin and Systemic Diseases
- (2012) G. Gaitanis et al. CLINICAL MICROBIOLOGY REVIEWS
- Inflammasome Activators Induce Interleukin-1α Secretion via Distinct Pathways with Differential Requirement for the Protease Function of Caspase-1
- (2012) Olaf Groß et al. IMMUNITY
- Oxidized Mitochondrial DNA Activates the NLRP3 Inflammasome during Apoptosis
- (2012) Kenichi Shimada et al. IMMUNITY
- Pyoderma Gangrenosum, Acne Conglobata, Suppurative Hidradenitis, and Axial Spondyloarthritis
- (2012) Vincenzo Bruzzese JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- Cutting Edge: FAS (CD95) Mediates Noncanonical IL-1 and IL-18 Maturation via Caspase-8 in an RIP3-Independent Manner
- (2012) L. Bossaller et al. JOURNAL OF IMMUNOLOGY
- Mutations in the γ-Secretase Genes NCSTN , PSENEN , and PSEN1 Underlie Rare Forms of Hidradenitis Suppurativa (Acne Inversa)
- (2012) Andrew E. Pink et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- One Target—Two Different Binding Modes: Structural Insights into Gevokizumab and Canakinumab Interactions to Interleukin-1β
- (2012) Michaela Blech et al. JOURNAL OF MOLECULAR BIOLOGY
- Beneficial Effect of Interleukin 1 Inhibition with Anakinra in Adult-onset Still's Disease. An Open, Randomized, Multicenter Study
- (2012) D. NORDSTROM et al. JOURNAL OF RHEUMATOLOGY
- Phosphorylation of NLRC4 is critical for inflammasome activation
- (2012) Yan Qu et al. NATURE
- The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP
- (2012) Geun-Shik Lee et al. NATURE
- Dectin-1 is an extracellular pathogen sensor for the induction and processing of IL-1β via a noncanonical caspase-8 inflammasome
- (2012) Sonja I Gringhuis et al. NATURE IMMUNOLOGY
- Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis
- (2012) Nicolino Ruperto et al. NEW ENGLAND JOURNAL OF MEDICINE
- Deficiency of Interleukin-1 Receptor Antagonist Responsive to Anakinra
- (2012) Charlotte Schnellbacher et al. PEDIATRIC DERMATOLOGY
- Critical role for calcium mobilization in activation of the NLRP3 inflammasome
- (2012) T. Murakami et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Use of Canakinumab, a Novel IL-1β Long-Acting Inhibitor, in Refractory Adult-Onset Still's Disease
- (2012) Apostolos Kontzias et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Canakinumab in Schnitzler Syndrome
- (2012) Steven Vanderschueren et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes
- (2011) J. B. Kuemmerle-Deschner et al. ANNALS OF THE RHEUMATIC DISEASES
- On-demand anakinra treatment is effective in mevalonate kinase deficiency
- (2011) E. J. Bodar et al. ANNALS OF THE RHEUMATIC DISEASES
- Psoriasis
- (2011) Gayathri K. Perera et al. Annual Review of Pathology-Mechanisms of Disease
- Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β
- (2011) H.H. van der Zee et al. BRITISH JOURNAL OF DERMATOLOGY
- Efficacy of Anti-Interleukin-1 Receptor Antagonist Anakinra (Kineret®) in a Case of Refractory Sweet’s Syndrome
- (2011) Nicolas Kluger et al. DERMATOLOGY
- Successful canakinumab treatment identifies IL-1β as a pivotal mediator in Schnitzler syndrome
- (2011) Heleen D. de Koning et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH)?a new autoinflammatory syndrome distinct from PAPA syndrome
- (2011) Markus Braun-Falco et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Non-canonical inflammasome activation targets caspase-11
- (2011) Nobuhiko Kayagaki et al. NATURE
- Inflammasome activation and IL-1 target IL-1 for secretion as opposed to surface expression
- (2011) A. Fettelschoss et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cytosolic DNA Triggers Inflammasome Activation in Keratinocytes in Psoriatic Lesions
- (2011) Y. Dombrowski et al. Science Translational Medicine
- Canakinumab (ACZ885, a fully human IgG1 anti-IL-1β mAb) induces sustained remission in pediatric patients with cryopyrin-associated periodic syndrome (CAPS)
- (2011) Jasmin B Kuemmerle-Deschner et al. ARTHRITIS RESEARCH & THERAPY
- Soluble interleukin-18 receptor complex is a novel biomarker in rheumatoid arthritis
- (2011) Satoko Takei et al. ARTHRITIS RESEARCH & THERAPY
- Current Status of Understanding the Pathogenesis and Management of Patients With NOMID/CINCA
- (2011) Raphaela Goldbach-Mansky Current Rheumatology Reports
- A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)
- (2010) P. Quartier et al. ANNALS OF THE RHEUMATIC DISEASES
- The Inflammasomes
- (2010) Kate Schroder et al. CELL
- Interleukin-1, inflammasomes and the skin
- (2010) Laurence Feldmeyer et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Blocking interleukin-1β in acute and chronic autoinflammatory diseases
- (2010) C. A. Dinarello JOURNAL OF INTERNAL MEDICINE
- A role for mitochondria in NLRP3 inflammasome activation
- (2010) Rongbin Zhou et al. NATURE
- NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
- (2010) Peter Duewell et al. NATURE
- Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome
- (2010) E. A. Miao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dysregulation of P2X7 receptor-inflammasome axis in SAPHO syndrome: successful treatment with anakinra
- (2010) M. Colina et al. RHEUMATOLOGY
- Interleukin-1 (IL-1) Pathway
- (2010) A. Weber et al. Science Signaling
- Immunological and Inflammatory Functions of the Interleukin-1 Family
- (2009) Charles A. Dinarello Annual Review of Immunology
- Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra
- (2009) M. Brenner et al. BRITISH JOURNAL OF DERMATOLOGY
- An Essential Role for the NLRP3 Inflammasome in Host Defense against the Human Fungal Pathogen Candida albicans
- (2009) Amy G. Hise et al. Cell Host & Microbe
- Inflammasome-Mediated Disease Animal Models Reveal Roles for Innate but Not Adaptive Immunity
- (2009) Susannah D. Brydges et al. IMMUNITY
- Glyburide inhibits the Cryopyrin/Nalp3 inflammasome
- (2009) Mohamed Lamkanfi et al. JOURNAL OF CELL BIOLOGY
- Listeria monocytogenes-Infected Human Peripheral Blood Mononuclear Cells Produce IL-1 , Depending on Listeriolysin O and NLRP3
- (2009) K. Meixenberger et al. JOURNAL OF IMMUNOLOGY
- A Critical Role for Hemolysins and Bacterial Lipoproteins in Staphylococcus aureus-Induced Activation of the Nlrp3 Inflammasome
- (2009) R. Munoz-Planillo et al. JOURNAL OF IMMUNOLOGY
- An Autoinflammatory Disease with Deficiency of the Interleukin-1–Receptor Antagonist
- (2009) Ivona Aksentijevich et al. NEW ENGLAND JOURNAL OF MEDICINE
- Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome
- (2009) Helen J. Lachmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- An Autoinflammatory Disease Due to Homozygous Deletion of theIL1RNLocus
- (2009) Sreelatha Reddy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of anakinra, an IL1 receptor antagonist, in refractory Sweet syndrome
- (2008) A Delluc et al. ANNALS OF THE RHEUMATIC DISEASES
- A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 trap) in patients with familial cold autoinflammatory syndrome
- (2008) Raphaela Goldbach-Mansky et al. ARTHRITIS AND RHEUMATISM
- Persistent efficacy of anakinra in patients with tumor necrosis factor receptor–associated periodic syndrome
- (2008) M. Gattorno et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of rilonacept (interleukin-1 trap) in patients with cryopyrin-associated periodic syndromes: Results from two sequential placebo-controlled studies
- (2008) Hal M. Hoffman et al. ARTHRITIS AND RHEUMATISM
- Active Caspase-1 Is a Regulator of Unconventional Protein Secretion
- (2008) Martin Keller et al. CELL
- What causes hidradenitis suppurativa?
- (2008) Lübeck Ralf Paus et al. EXPERIMENTAL DERMATOLOGY
- Function of Nod-like receptors in microbial recognition and host defense
- (2008) Luigi Franchi et al. IMMUNOLOGICAL REVIEWS
- Resveratrol directly targets COX-2 to inhibit carcinogenesis
- (2008) Tatyana A. Zykova et al. MOLECULAR CARCINOGENESIS
- The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response
- (2008) Daniel A. Muruve et al. NATURE
- Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization
- (2008) Veit Hornung et al. NATURE IMMUNOLOGY
- The NALP3 inflammasome is involved in the innate immune response to amyloid-β
- (2008) Annett Halle et al. NATURE IMMUNOLOGY
- A NOD2-NALP1 complex mediates caspase-1-dependent IL-1 secretion in response to Bacillus anthracis infection and muramyl dipeptide
- (2008) L.-C. Hsu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mutations in NALP12 cause hereditary periodic fever syndromes
- (2008) I. Jeru et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
- (2008) C. Dostert et al. SCIENCE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started